Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
This is an observational study for patients with prostate cancer that will be treated with Androgen Deprivation Therapy. The study will help the investigators learn more about how these medications affect the heart and how those effects relate to patients' medical history and social determinants of health (such as race, gender identity, education, occupation, access to health services and economic resources). Patients on this study will have echocardiograms, blood draws, and answer questions about their symptoms and activity level. Patients will be followed on this study for up to 5 years.
Official title: Cardiotoxicity of Prostate Cancer Therapy: Mechanisms, Predictors, and Social Determinants of Health in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2021-10-27
Completion Date
2029-11
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
Social Determinants of Health
We will perform detailed phenotyping of Social Determinants of Health using the National Institute of Minority Health and Health Disparities PhenX SDOH toolkit at baseline.
Locations (1)
University of Pennsylvania
Philadelphia, Pennsylvania, United States